Non-invasive fetal RHD genotyping in the first trimester of pregnancy

Clinical Chemistry and Laboratory Medicine

Volumn 48, Issue 8, 2010, Pages 1121-1126

  Cardo, Leyre ^a   García, Belén Prieto ^a   Alvarez, Francisco V ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

Author keywords

fetal DNA; fetal RHD genotype; real time PCR

Indexed keywords

BETA GLOBIN; DNA; RHESUS D ANTIBODY;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DNA EXTRACTION; EXON; FEMALE; FIRST TRIMESTER PREGNANCY; GENE AMPLIFICATION; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PREGNANT WOMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BETA-GLOBINS; EXONS; FEMALE; FETAL DISEASES; GENOTYPE; GESTATIONAL AGE; HUMANS; MATERNAL-FETAL EXCHANGE; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; RH-HR BLOOD-GROUP SYSTEM; SENSITIVITY AND SPECIFICITY;

EID: 77955439511     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2010.234     Document Type: Article

References (37)

1. Pilgrim H, Lloyd-Jones M, Rees A. Routine antenatal anti-D prophylaxis for RhD-negative women: a systematic review and economic evaluation. Health Technol Assess 2009;13:iii, ix-iii, 103.
2. Kumar S, Regan F. Management of pregnancies with RhD alloimmunisation. Br Med J 2005;330:1255-1258
3. Lo YM, Corbetta N, Chamberlain PF, Rai V, Sargent IL, Redman CW, et. al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-487
4. Urbaniak SJ. The scientific basis of antenatal prophylaxis. Br J Obstet Gynaecol 1998;105(Suppl 18):11-18
5. Lo YM, Tein MS, Lau TK, Haines CJ, Leung TN, Poon PM, et. al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998;62:768-775
6. Zhang Y, Li Q, Hui N, Fei M, Hu Z, Sun S. Effect of formaldehyde treatment on the recovery of cell-free fetal DNA frommaternal plasma at different processing times. Clin Chim Acta 2008;397:60-64
7. Li Y, Holzgreve W, Hahn S. Size fractionation of cell-free DNA in maternal plasma and its application in noninvasive detection of fetal single gene point mutations. Method Mol Biol 2008; 444:239-251
8. Legler TJ, Liu Z, Heermann KH, Hempel M, Gutensohn K, Kiesewetter H, et. al. Specific magnetic bead-based capture of free fetal DNA from maternal plasma. Transfus Apher Sci 2009;40:153-157
9. van der Schoot CE, Soussan AA, Koelewijn J, Bonsel G, Paget- Christiaens LG, de Haas M. Non-invasive antenatal RHD typing. Transfus Clin Biol 2006;13:53-57
10. Gautier E, Benachi A, Giovangrandi Y, Ernault P, Olivi M, Gaillon T, et. al. Fetal RhD genotyping by maternal serum analysis: a two-year experience. Am J Obstet Gynecol 2005;192:666-669
11. Rouillac-Le Sciellour C, Puillandre P, Gillot R, Baulard C, Metral S, Le Van KC, et. al. Large-scale pre-diagnosis study of fetal RHD genotyping by PCR on plasma DNA from RhDnegative pregnant women. Mol Diagn 2004;8:23-31.
12. Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann NY Acad Sci 2004;1022:119-123
13. Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood - a meta-analysis. Am J Obstet Gynecol 2006;195:1163-1173
14. Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et. al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 2009;55:611-622
15. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, et. al. The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med 2003;138:W1-12.
16. Legler TJ, Heermann KH, Liu Z, Soussan AA, van der Schoot CE. Fetal DNA: strategies for optimal recovery. Method Mol Biol 2008;444:209-218
17. Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42:1079-1085
18. Legler TJ, Liu Z, Mavrou A, Finning K, Hromadnikova I, Galbiati S, et. al. Workshop report on the extraction of foetal DNA from maternal plasma. Prenat Diagn 2007;27:824-829
19. Muller SP, Bartels I, Stein W, Emons G, Gutensohn K, Kohler M, et. al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion 2008;48:2292-2301
20. Invernizzi P, Biondi ML, Battezzati PM, Perego F, Selmi C, Cecchini F, et. al. Presence of fetal DNA in maternal plasma decades after pregnancy. Hum Genet 2002;110:587-591
21. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, et. al. Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 2001;41:1524-1530
22. Benachi A, Steffann J, Gautier E, Ernault P, Olivi M, Dumez Y, et. al. Fetal DNA in maternal serum: does it persist after pregnancy? Hum Genet 2003;113:76-79
23. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM. Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999;64:218-224
24. Finning K, Martin P, Summers J, Massey E, Poole G, Daniels G. Effect of high throughput RHD typing of fetal DNA in maternal plasma on use of anti-RhD immunoglobulin in RhD negative pregnant women: prospective feasibility study. Br Med J 2008;336:816-818
25. Costa JM, Giovangrandi Y, Ernault P, Lohmann L, Nataf V, El Halali N, et. al. Fetal RHD genotyping in maternal serum during the first trimester of pregnancy. Br J Haematol 2002;119:255-260
26. Bianchi DW. Circulating fetal DNA: its origin and diagnostic potential - a review. Placenta 2004;25(Suppl A):S93-101.
27. Bischoff FZ, Lewis DE, Simpson JL. Cell-free fetal DNA in maternal blood: kinetics, source and structure. Hum Reprod Update 2005;11:59-67.
28. Lo YM. Fetal DNA in maternal plasma. Ann NY Acad Sci 2000;906:141-147
29. Lapaire O, Volgmann T, Grill S, Hosli I, Zanetti-Daellenbach R, Zhong XY, et. al. Significant correlation between maternal body mass index at delivery and in the second trimester, and second trimester circulating total cell-free DNA levels. Reprod Sci 2009;16:274-279
30. Wataganara T, Peter I, Messerlian GM, Borgatta L, Bianchi DW. Inverse correlation between maternal weight and second trimester circulating cell-free fetal DNA levels. Obstet Gynecol 2004;104:545-550
31. Lazar L, Rigo J Jr, Nagy B, Balogh K, Mako V, Cervenak L, et. al. Relationship of circulating cell-free DNA levels to cellfree fetal DNA levels, clinical characteristics and laboratory parameters in preeclampsia. BMC Med Genet 2009;10:120.
32. Stenczer B, Rigo J Jr, Prohaszka Z, Derzsy Z, Lazar L, Mako V, et. al. Plasma osteopontin concentrations in preeclampsia: is there an association with endothelial injury? Clin Chem Lab Med 2010;48:181-187
33. Molvarec A, Rigo J Jr, Lazar L, Balogh K, Mako V, Cervenak L, et. al. Increased serum heat-shock protein 70 levels reflect systemic inflammation, oxidative stress and hepatocellular injury in preeclampsia. Cell Stress Chaperones 2009;14:151-159
34. Contreras M. The prevention of Rh haemolytic disease of the fetus and newborn - general background. Br J Obstet Gynaecol 1998;105(Suppl 18):7-10.
35. Avent ND, Reid ME. The Rh blood group system: a review. Blood 2000;95:375-387
36. Stockman JA III. Overview of the state of the art of Rh disease: history, current clinical management, and recent progress. J Pediatr Hematol Oncol 2001;23:554-562
37. Ulm B, Svolba G, Ulm MR, Bernaschek G, Panzer S. Male fetuses are particularly affected by maternal alloimmunization to D antigen. Transfusion 1999;39:169-173